文献速递血液净化与透析水电解质与酸碱

血液透析患者矿物质骨代谢异常与死亡率的关系因残余肾功能而异

Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-05-09

本研究在35114例美国新发血液透析患者中,按残余肾尿素清除率分层(<1.5、1.5-<3.0、≥3.0 ml/min/1.73m²),分析血清磷、校正钙、全段甲状旁腺激素和碱性磷酸酶与全因死亡率的关联。中位随访1.3年,8102例(23%)死亡。残余肾功能修饰了血清磷和全段甲状旁腺激素与死亡率的关联,而校正钙和碱性磷酸酶的关联不受残余肾功能影响。

要点

  • 血清磷升高与死亡率增加相关,在残余肾尿素清除率较高患者中更显著(P交互=0.001)。
  • 低全段甲状旁腺激素在低残余肾尿素清除率(<1.5)患者中与高死亡率相关;高全段甲状旁腺激素在较高残余肾尿素清除率(≥1.5)患者中与高死亡率相关(P交互<0.001)。
  • 校正钙和碱性磷酸酶升高与死亡率增加相关,且不受残余肾尿素清除率分层影响(P交互分别为0.34和0.53)。

核心结论

  • 在新生血液透析患者中,残余肾功能修饰了血清磷和全段甲状旁腺激素与全因死亡率的关联。

研究设计与样本

  • 回顾性队列研究,纳入2007-2011年美国一家大型透析机构35114例新发血液透析患者。
  • 按基线残余肾尿素清除率分为<1.5、1.5-<3.0和≥3.0 ml/min/1.73m²三层,采用Cox模型校正临床特征和实验室指标。

主要发现

  • 中位随访1.3年(四分位距0.6-2.3年),共8102例(23%)死亡。
  • 血清磷浓度越高,死亡风险递增,且在残余肾尿素清除率较高患者中更明显(P交互=0.001)。
  • 低全段甲状旁腺激素在残余肾尿素清除率<1.5 ml/min/1.73m²患者中与较高死亡率相关;高全段甲状旁腺激素在残余肾尿素清除率≥1.5 ml/min/1.73m²患者中与较高死亡率相关(P交互<0.001)。
  • 校正总钙和碱性磷酸酶升高与死亡率增加相关(趋势P均<0.001),且不受残余肾尿素清除率分层影响(P交互分别为0.34和0.53)。

临床怎么用

  • 评估血液透析患者矿物质骨代谢异常相关死亡风险时,应考虑残余肾功能分层。
  • 对残余肾功能较高的患者,需关注高血清磷和高全段甲状旁腺激素的死亡风险;对残余肾功能较低者,需关注低全段甲状旁腺激素的风险。

局限性

  • 原文未报告观察性设计之外的因果推断限制,需参考原文讨论部分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The relationship between mineral and bone disorders and survival according to residual kidney function status has not been previously studied in patients on hemodialysis. We hypothesized that residual kidney function, defined by renal urea clearance, modifies the association between mineral and bone disorder parameters and mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The associations of serum phosphorus, albumin-corrected calcium, intact parathyroid hormone, and alkaline phosphatase with all-cause mortality were examined across three strata (<1.5, 1.5 to <3.0, and ≥3.0 ml/min per 1.73 m2) of baseline residual renal urea clearance using Cox models adjusted for clinical characteristics and laboratory measurements in 35,114 incident hemodialysis patients from a large United States dialysis organization over the period of 2007-2011. RESULTS: A total of 8102 (23%) patients died during the median follow-up of 1.3 years (interquartile range, 0.6-2.3 years). There was an incremental mortality risk across higher serum phosphorus concentrations, which was pronounced among patients with higher residual renal urea clearance (Pinteraction=0.001). Lower concentrations of serum intact parathyroid hormone were associated with higher mortality among patients with low residual renal urea clearance (i.e., <1.5 ml/min per 1.73 m2), whereas higher concentrations showed a higher mortality risk among patients with greater residual renal urea clearance (i.e., ≥1.5 ml/min per 1.73 m2; Pinteraction<0.001). Higher serum corrected total calcium and higher alkaline phosphatase concentrations consistently showed higher mortality risk (Ptrend<0.001 for both) irrespective of residual renal urea clearance strata (Pinteraction=0.34 and Pinteraction=0.53, respectively). CONCLUSIONS: Residual kidney function modified the mortality risk associated with serum phosphorus and intact parathyroid hormone among incident hemodialysis patients. Future studies are needed to examine whether taking account for residual kidney function into the assessment of mortality risk associated with serum phosphorus and intact parathyroid hormone improves patient management and clinical outcomes in the hemodialysis population.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Wang M, Obi Y, Streja E, et al. Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function. Clin J Am Soc Nephrol. 2017. PMID: 28487345. doi:10.2215/CJN.11931116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。